Abstract
Get full access to this article
View all access options for this article.
References
1.
Lockman
LA
Hunninghake
DB
Krivit
W
Desnick
RJ
. Relief of pain of Fabry's disease by diphenylhydantoin . Neurology
1973 ; 23 : 871 –5 .
2.
Eadie
MJ
Tyrer
JH
. Anticonvulsant therapy. Pharmacological basic and practice . 2nd ed . Edinburgh : Churchill Livingstone , 1980 .
3.
Bauer
EA
Cooper
TW
Tucker
DR
. Phenytoin therapy of recessive dystrophic epidermolysis bullosa: Clinical trial and proposed mechanism of action on collagenase . N Engl J Med
1980 ; 303 : 776 –81 .
4.
Eisenberg
M
Stevens
LH
Schofield
PJ
. Epidermolysis bullosa: New therapeutic approaches . Aust J Dermatol
1978 ; 19 : 1 –8 .
5.
Einsen
AZ
. Human skin collagenase: Relationship to the pathogenesis of epidermolysis bullosa dystrophica . J Invest Dermatol
1969 ; 52 : 449 –53 .
6.
Bauer
EA
Tabas
M
. A perspective on the role of collagenase in recessive dystrophic epidermolysis bullosa . Arch Dermatol
1969 ; 124 : 734 –6 .
7.
Cunnane
SC
Kent
ET
McAdoo
KR
. Abnormalities of plasma and erythrocyte essential fatty acid composition in epidermolysis bullosa: Influence of treatment with diphenylhydantoin . J Invest Dermatol
1987 ; 89 : 395 –9 .
8.
Fine
JD
Johnson
L
. Efficacy of systemic phenytoin in the treatment of functional epidermolysis bullosa . Arch Dermatol
1988 ; 124 : 1402 –6 .
9.
Chalmers
RJG
Shuster
S
. Dominant dystrophic epidermolysis bullosa . Arch Dermatol
1984 ; 120 : 707 –8 .
10.
Jenkinson
HA
Burrows
D
Tidman
MJ
. Epidermolysis bullosa . Br J Dermatol
1984 ; 3 (suppl ): 73 .
11.
Rogers
RB
Yancey
KB
Allen
BS
. Phenytoin therapy for junctional epidermolysis bullosa . Arch Dermatol
1983 ; 119 : 925 –6 .
12.
Cooper
TW
Bauer
EA
. Therapeutic efficacy of phenytoin in recessive dystrophic epidermolysis . Arch Dermatol
1984 ; 120 : 490 –5 .